Dr. Tara E Seery, MD
Claim this profileHoag Memorial Hospital Presbyterian
Studies Pancreatic Cancer
Studies Cancer
7 reported clinical trials
18 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
2Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Tara E Seery, MD is currently running
M-CENK
for Advanced or Metastatic Cancer
This is a two-part, open-label phase 1 study to evaluate safety and preliminary efficacy of M-CENK Suspension for Infusion, Cryopreserved, and N-803 for subcutaneous administration in subjects with locally advanced or metastatic solid tumors. The study consists of two cohorts: cohort 1 includes subjects with either newly diagnosed solid tumors who have not received prior therapy or subjects who have received prior first line treatment; and cohort 2 that includes subjects with relapsed/refractory (r/r) solid tumors who have progressive disease after receiving ≥ 2 prior therapies. The two cohorts will be conducted simultaneously.
Recruiting1 award Phase 1
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
More about Tara E Seery, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Tara E Seery, MD has experience with
- N-803
- Nab-paclitaxel
- Gemcitabine
- XB2001
- Leucovorin
- Aldoxorubicin HCl
Breakdown of trials Tara E Seery, MD has run
Pancreatic Cancer
Cancer
Healthy Subjects
Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tara E Seery, MD specialize in?
Tara E Seery, MD focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Tara E Seery, MD currently recruiting for clinical trials?
Yes, Tara E Seery, MD is currently recruiting for 2 clinical trials in Newport Beach California. If you're interested in participating, you should apply.
Are there any treatments that Tara E Seery, MD has studied deeply?
Yes, Tara E Seery, MD has studied treatments such as N-803, Nab-paclitaxel, Gemcitabine.
What is the best way to schedule an appointment with Tara E Seery, MD?
Apply for one of the trials that Tara E Seery, MD is conducting.
What is the office address of Tara E Seery, MD?
The office of Tara E Seery, MD is located at: Hoag Memorial Hospital Presbyterian, Newport Beach, California 92663 United States. This is the address for their practice at the Hoag Memorial Hospital Presbyterian.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.